SiteRx
SiteRx is a New York-based health technology company that operates an AI-tagged Clinical Intelligence Platform for diverse patient identification and recruitment in clinical trials, serving pharmaceutical sponsors and research organizations through a HIPAA- and SOC 2 Type 2-compliant platform with a dedicated physician portal.
- Company typePrivate
- Founded2019
- HeadquartersNew York, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What SiteRx does
SiteRx is a private, New York-based health technology company that operates an AI-tagged Clinical Intelligence Platform focused on patient identification and recruitment for clinical research. The platform is positioned to enable more diverse and efficient patient identification for clinical trials, with a stated mission of expanding access, lowering barriers to entry, and increasing participation and representation in clinical research within diverse communities. The company's primary customer segment is clinical trial sponsors, encompassing pharmaceutical companies and research organizations that run trials and struggle with patient identification and diversity in enrollment. Distribution operates through two channels: the main corporate website targeting sponsor-side enterprise buyers and a dedicated physician portal at physician.siterx.health that gives healthcare providers access to platform services.
The company was founded in 2019 by CEO Seth Goodman, whose motivation stems from watching his father dedicate his career to Alzheimer's disease patients, and the platform carries an explicit long-term mission tied to Alzheimer's research. SiteRx's product surface is intentionally narrow: a single unified Clinical Intelligence Platform rather than a multi-product suite. The platform is described as a novel approach to patient identification, but the underlying technology, model architecture, and data assets are not publicly detailed. No patents, no API surface, no disclosed SDKs, and no named AI/ML models are referenced in the available inputs. The company holds SOC 2 Type 2 certification and maintains HIPAA-compliant data handling, with CCPA-aligned privacy practices, indicating a deliberate enterprise-readiness posture around security and compliance given the sensitivity of clinical and patient data.
SiteRx's commercial mechanics are not publicly disclosed: no pricing model, no contract structures, no named customers, and no revenue figures are available. The company is founder-owned with no disclosed institutional investors beyond a 2021 financing involving CoFound Partners and Vast Ventures, and no parent company or subsidiaries exist. Marketing relies on standard digital channels (Google Analytics, Meta Pixel) for top-of-funnel awareness. The combination of a single-product platform, undisclosed revenue, a 51-100 employee organization, and a 2021-vintage funding event positions SiteRx as an early-to-mid stage vendor in the clinical trial patient recruitment category, competing primarily on its diversity-and-inclusion mission framing and its compliance credentials rather than on disclosed technical or commercial scale.
SiteRx firmographics
Firmographics- Name
- SiteRx
- Legal name
- SiteRx, Inc.
- Website
- https://siterx.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- SiteRx is a New York-based health technology company that operates an AI-tagged Clinical Intelligence Platform for diverse patient identification and recruitment in clinical trials, serving pharmaceutical sponsors and research organizations through a HIPAA- and SOC 2 Type 2-compliant platform with a dedicated physician portal.
- Ownership category
- akta.pro rank
SiteRx industry classification
Industry- Product category
- Clinical Trial Patient Recruitment
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210)
- SIC
- Services-Computer Programming, Data Processing, Etc. (7370), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ)
- akta.pro secondary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
Keywords
Where SiteRx is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
SiteRx business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Distribution channels1 record
Marketing channels2 records
SiteRx product offering
Product offeringCore offering
SiteRx offers a Clinical Intelligence Platform that uses AI to identify and recruit diverse patient populations for clinical trials. The platform enables pharmaceutical sponsors and research organizations to expand access to clinical research, lower barriers to participation, and increase representation across diverse communities. A dedicated physician portal allows healthcare providers to engage with the platform.
Product overview
SiteRx offers a single unified product: the Clinical Intelligence Platform. This platform is designed to democratize access to clinical research by enabling diverse and efficient patient identification. The company focuses on expanding clinical trial access, lowering barriers to entry, and promoting diversity and inclusion in clinical research, with a long-term mission to revolutionize healthcare delivery to patients and ultimately deliver the first cure for Alzheimer's disease.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Intelligence Platform An AI-powered clinical research platform that enables diverse and efficient patient identification and recruitment for clinical trials. It is used by pharmaceutical sponsors, research organizations, and physicians to expand clinical trial access, lower participation barriers, and increase representation across diverse communities.
Companies that use SiteRx
Customer profileSegments1 record
Ideal customer profiles2 records
SiteRx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
SiteRx partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights5 records
SiteRx competitors and assessment
Company assessmentEmerging players
- Evidation Health: Evidation operates a large consented patient engagement and data platform used for clinical research recruitment and real-world evidence. It is comparable as an emerging player bridging consumer health engagement with research-grade recruitment.
- Castor: Castor offers an electronic data capture and decentralized clinical trial platform with patient recruitment capabilities. It overlaps with SiteRx on the trial-enablement workflow, particularly for academic and emerging biotech sponsors.
Direct peers
- Trial Library: Trial Library focuses on clinical trial recruitment with an explicit emphasis on community-based and diverse patient populations. It shares SiteRx's mission-driven positioning around equitable trial access.
- Antidote (formerly TrialReach): Antidote provides a clinical trial matching platform connecting patients to studies, with emphasis on condition-specific and diverse recruitment. It is a direct comparable on the patient-facing trial matching layer.
- Mendel: Mendel builds an AI platform for clinical trial patient recruitment and real-world data extraction from unstructured medical records. It competes head-on with SiteRx in using AI to match patients to trials at the site level.
- Deep 6 AI: Deep 6 AI applies AI to patient identification and cohort building for clinical trials, directly overlapping with SiteRx's Clinical Intelligence Platform. Both target pharma sponsors and investigators seeking faster, more diverse recruitment.
Broad incumbents
- IQVIA: IQVIA is the largest clinical research services and technology vendor globally, offering patient recruitment alongside broader trial operations, data, and analytics. It represents the broad incumbent SiteRx must displace in enterprise pharma accounts.
- Medidata (Dassault Systèmes): Medidata provides the leading clinical trial data and operations platform used by most large sponsors. Its Rave platform competes indirectly with SiteRx by anchoring sponsor workflows upstream of recruitment.
- Veeva Systems: Veeva offers clinical, regulatory, and quality software used across pharma R&D. While not focused solely on recruitment, it is the strategic platform incumbent whose suite contracts SiteRx must either fit into or compete against.
- Verily (Alphabet): Verily runs clinical research platforms, including site networks and patient recruitment tools backed by Alphabet capital. It is a broad incumbent competing for the same enterprise pharma recruitment and decentralized trial budgets as SiteRx.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
SiteRx social profiles
Digital presenceSiteRx compliance and trust
Trust signalCompliance3 records
SiteRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
SiteRx leadership team
Management profileNumber of profiles
Profiles5 records
SiteRx funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SiteRx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SiteRx
What does SiteRx do?
SiteRx offers a Clinical Intelligence Platform that uses AI to identify and recruit diverse patient populations for clinical trials. The platform enables pharmaceutical sponsors and research organizations to expand access to clinical research, lower barriers to participation, and increase representation across diverse communities. A dedicated physician portal allows healthcare providers to engage with the platform.
Is SiteRx a public or private company?
SiteRx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was SiteRx founded?
SiteRx was founded in 2019. It employs 51 to 100 people.
Where is SiteRx based?
SiteRx is headquartered in New York, United States, in the North America region.
Who are SiteRx's main competitors?
Emerging players on record are Evidation Health and Castor. Direct peers are Trial Library, Antidote (formerly TrialReach), Mendel and Deep 6 AI. Broad incumbents are IQVIA, Medidata (Dassault Systèmes), Veeva Systems and Verily (Alphabet).
Does SiteRx have an API?
No public API is recorded for SiteRx.
What industry is SiteRx in?
SiteRx's product category is Clinical Trial Patient Recruitment. Its primary akta.pro industry code is HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation), with a secondary code of HLAGACAE, Clinical Trial Site Operations & Study Coordination. Its NAICS code is 518210 and its SIC code is 7370.